Announcements Trials
Browse Landscape

Phase

Phase 2 109Phase 3 40Phase 1 18Phase NA 15Phase 1/2 12Phase 2/3 9Phase 4 2Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 113INDUSTRY 61OTHER_GOV 6NETWORK 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 3Thoracic 2Plasma cell 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Pleural Effusion, Malignant 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Pleurodesis 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × NETWORK × Thoracic × Clear all
NCT01670786 2014-05-13

Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion

Grupo de Pesquisa em Pleura e Oncologia Toracica

Phase 4 Completed
60 enrolled
Thoracic

Pleural Effusion, Malignant

NCT00883675 2013-12-18

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Maestro Clinical, Inc.

Phase 4 Completed
133 enrolled 8 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡